IPRIPR2023-00933Terminated-Settled
Samsung Bioepis Co., Ltd.v.Alexion Pharmaceuticals, Inc. et al.
IPR challenge of US 9732149.
Type
IPR
Filed
May 18, 2023
Instituted
Dec 8, 2023
Decided
Sep 4, 2024
Patent
Application
15284015
Inventor
Leonard BELL et al
Granted
Aug 15, 2017
01
Timeline
3 milestones
2023-05-18Petition filed
2023-12-08Institution
2024-09-04Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Rhyu, Michelleet al
Patent Owner
Alexion Pharmaceuticals, Inc. et al.
Counsel
Flattmann, Geraldet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →